Growth Metrics

Opko Health (OPK) Depreciation & Amortization (CF) (2016 - 2025)

Opko Health (OPK) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $22.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 6.93% year-over-year to $22.4 million, compared with a TTM value of $91.6 million through Dec 2025, down 6.67%, and an annual FY2025 reading of $91.6 million, down 6.67% over the prior year.
  • Depreciation & Amortization (CF) was $22.4 million for Q4 2025 at Opko Health, down from $22.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $28.0 million in Q2 2022 and bottomed at $19.0 million in Q3 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $24.2 million, with a median of $24.2 million recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) dropped 9.85% in 2021, then soared 47.63% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $19.2 million in 2021, then surged by 37.88% to $26.5 million in 2022, then decreased by 1.81% to $26.0 million in 2023, then dropped by 7.48% to $24.0 million in 2024, then decreased by 6.93% to $22.4 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for OPK at $22.4 million in Q4 2025, $22.7 million in Q3 2025, and $23.0 million in Q2 2025.